Results 101-120 of 24,567 for speaker:Róisín Shortall

Written Answers — Department of Health: Medicinal Products (5 Nov 2024)

Róisín Shortall: 1293. To ask the Minister for Health the steps he is taking to address the shortage of a medication used to treat and manage polycythemia vera (details supplied); if an alternative medication is being considered for approval for reimbursement; and if he will make a statement on the matter. [45282/24]

Health Insurance (Amendment) Bill 2024: Committee and Remaining Stages (23 Oct 2024)

Róisín Shortall: What is the timeline involved? Is it years away?

Health Insurance (Amendment) Bill 2024: Committee and Remaining Stages (23 Oct 2024)

Róisín Shortall: On a point of order, everybody is pressed for time and the Minister is going way off the script.

Health Insurance (Amendment) Bill 2024: Committee and Remaining Stages (23 Oct 2024)

Róisín Shortall: It is one thing to respond to points raised but the Minister is going way off the subject.

Health Insurance (Amendment) Bill 2024: Instruction to Committee (23 Oct 2024)

Róisín Shortall: I very much welcome this motion to allow for amendments outside the scope of the original health insurance Bill. The amendments brought forward by the Minister will, if passed, provide the statutory basis for free HRT, as we have been told. It is true to say that for too long women's healthcare has been sidelined but, thankfully, that is changing. There are still numerous examples of...

Health Insurance (Amendment) Bill 2024: Second Stage (23 Oct 2024)

Róisín Shortall: This is the annual practice of committing to the provisions of this legislation relating to the private health insurance market to provide for community rating and risk equalisation. It is a technical measure. In the context of a private health insurance market, it makes sense not to have cherry-picking by some of the newer entrants into the market or any kind of marketing to attract...

Public Health Service Staffing: Motion (Resumed) [Private Members] (23 Oct 2024)

Róisín Shortall: I thank the Labour Party for tabling this motion on staffing levels in the HSE. The Social Democrats are happy to support it. There is no doubt that in recent weeks there have been several claims and counterclaims. This has made it difficult to get to the truth of the matter and the facts. The Minister's plan seems to be to muddy the waters instead of engaging in any kind of meaningful...

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Róisín Shortall: I will have to leave shortly to go to the Chamber as well. I find it hard to understand how we get to a point where the cardiac strategy is five years out of date and we are only now talking about a new strategy. When was the Nolan report completed?

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Róisín Shortall: In that case, it was completed nearly two years ago. What kind of engagement has the Irish Cardiac Society had with the Department of Health, the Minister or anybody at a senior level in the HSE on a new strategy?

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Róisín Shortall: Is Professor McAdam saying we would be required to have a national strategy under development at European level?

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Róisín Shortall: The likelihood is, even if there is cognisance taken of European developments, that we are talking about developing a new strategy, which would likely take some time.

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Róisín Shortall: That issue will not change quickly, unfortunately. We have been looking for the health strategy to be implemented for a long time. Regarding the recent session in Budapest, given the importance of cardiovascular disease and the fact it is the second biggest contributor to mortality, it strikes me, and it is disappointing, that the senior Minister was not there. That is just a comment. ...

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Róisín Shortall: Yes, but what is the split?

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Róisín Shortall: I would also add in the commercial determinants of health. We have been doing a lot of work on that and issues related to drinking, smoking, fast food and all of that. There are big commercial pressures brought to bear on government related to that. I think the area of commercial determinants should be included in that because there is those big industries have considerable access to...

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Róisín Shortall: Okay, but at the end of that Professor McAdam is saying only 5% of people have inherited conditions.

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Róisín Shortall: What does the screening entail? Is it very costly or why is it so underdeveloped?

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Róisín Shortall: For child screening, when or how is that done?